Labella

Levonorgestrel, the active ingredient in Labella, is a progestin presented as an oral tablet for oral use. It is employed for emergency contraception and for the ongoing prevention of pregnancy in women of reproductive age by inhibiting ovulation and altering the uterine environment.

GNH USA supplies Labella as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution, ensuring product integrity throughout the supply chain.

Levonorgestrel is a progestin used in hormonal contraceptive pathways.

- Emergency contraception: prevents pregnancy when taken within 72‑120 hours after unprotected intercourse. - Regular contraception: used as a single‑dose or part of a hormonal regimen to provide ongoing pregnancy prevention. - Hormonal contraceptive for women of reproductive age: offers a progestin‑only option for those who cannot use estrogen‑containing methods.

Levonorgestrel may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Abdominal pain: cramping or discomfort in the lower abdomen. - Menstrual changes: spotting, early or delayed periods. - Dizziness: brief episodes of light‑headedness. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Chest pain: may indicate cardiovascular involvement. - Severe abdominal pain: could signal ectopic pregnancy. - Liver dysfunction: jaundice or abnormal liver tests. - Vision changes: blurred or double vision.

Levonorgestrel should be used with attention to specific safety considerations.

- Pregnancy contraindication: avoid use if already pregnant. - Hepatic impairment: use with caution in patients with liver disease. - Hypersensitivity: discontinue if allergic reaction occurs. - Breast cancer: not recommended for women with active estrogen‑dependent tumors. - Drug interactions: consider potential reduction of efficacy with enzyme‑inducing agents. - Store at room temperature: keep in the original pack, protect from moisture.

Levonorgestrel may interact with other medicines, affecting its effectiveness.

Major Interactions (Avoid): - Rifampicin: strong enzyme inducer that can markedly reduce contraceptive efficacy. - St. John’s wort: herbal inducer that may diminish hormonal activity.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may alter hormone metabolism. - Antiretroviral efavirenz: can decrease contraceptive effectiveness. - Anticonvulsants (e.g., phenytoin): may modestly reduce levonorgestrel levels.